Lee MS - Search Results

1

Lee MS, Sanoff HK. Lee MS, et al. BMJ. 2020 Dec 7;371:m4050. doi: 10.1136/bmj.m4050. BMJ. 2020. PMID: 33288500 Review.

2

Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.

Sanoff HK, Moon DH, Moore DT, Boles J, Bui C, Blackstock W, O'Neil BH, Subramaniam S, McRee AJ, Carlson C, Lee MS, Tepper JE, Wang AZ. Sanoff HK, et al. Among authors: lee ms. Nanomedicine. 2019 Jun;18:189-195. doi: 10.1016/j.nano.2019.02.021. Epub 2019 Mar 8. Nanomedicine. 2019. PMID: 30858085 Free PMC article. Clinical Trial.

3

Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib.

Liu Y, Lyu J, Bell Burdett K, Sibley AB, Hatch AJ, Starr MD, Brady JC, Hammond K, Marmorino F, Rossini D, Goldberg RM, Falcone A, Cremolini C, Owzar K, Ivanova A, Moore DT, Lee MS, Sanoff HK, Innocenti F, Nixon AB. Liu Y, et al. Among authors: lee ms. Mol Cancer Ther. 2020 Oct;19(10):2146-2154. doi: 10.1158/1535-7163.MCT-20-0249. Epub 2020 Aug 3. Mol Cancer Ther. 2020. PMID: 32747417

4

Molecular and Clinical Characterization of a Claudin-Low Subtype of Gastric Cancer.

Nishijima TF, Kardos J, Chai S, Smith CC, Bortone DS, Selitsky SR, Parker JS, Sanoff HK, Lee MS, Vincent BG. Nishijima TF, et al. Among authors: lee ms. JCO Precis Oncol. 2017 Nov;1:1-10. doi: 10.1200/PO.17.00047. JCO Precis Oncol. 2017. PMID: 35172495

5

Phase II Single-Arm Study of Palbociclib and Cetuximab Rechallenge in Patients with KRAS/NRAS/BRAF Wild-Type Colorectal Cancer.

Sorah JD, Moore DT, Reilley MJ, Salem ME, Triglianos T, Sanoff HK, McRee AJ, Lee MS. Sorah JD, et al. Among authors: lee ms. Oncologist. 2022 Dec 9;27(12):1006-e930. doi: 10.1093/oncolo/oyac222. Oncologist. 2022. PMID: 36288238 Free PMC article. Clinical Trial.

6

Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?

Lee MS, O'Neil BH. Lee MS, et al. J Gastrointest Oncol. 2016 Oct;7(5):804-818. doi: 10.21037/jgo.2016.08.05. J Gastrointest Oncol. 2016. PMID: 27747094 Free PMC article. Review.

7

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.

Lee MS, Ryoo BY, Hsu CH, Numata K, Stein S, Verret W, Hack SP, Spahn J, Liu B, Abdullah H, Wang Y, He AR, Lee KH; GO30140 investigators. Lee MS, et al. Among authors: lee kh. Lancet Oncol. 2020 Jun;21(6):808-820. doi: 10.1016/S1470-2045(20)30156-X. Lancet Oncol. 2020. PMID: 32502443 Clinical Trial.

8

Clinical genetics in breast cancer.

Ntowe KW, Lee MS, Plichta JK. Ntowe KW, et al. Among authors: lee ms. J Surg Oncol. 2024 Apr 1. doi: 10.1002/jso.27630. Online ahead of print. J Surg Oncol. 2024. PMID: 38557982

9

Atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma - Authors' replys.

Lee KH, Lee MS. Lee KH, et al. Among authors: lee ms. Lancet Oncol. 2020 Sep;21(9):e413. doi: 10.1016/S1470-2045(20)30476-9. Lancet Oncol. 2020. PMID: 32888463 No abstract available.

10

Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplant.

Bratton EW, El Husseini N, Chastain CA, Lee MS, Poole C, Stürmer T, Juliano JJ, Weber DJ, Perfect JR. Bratton EW, et al. Among authors: lee ms. PLoS One. 2012;7(8):e43582. doi: 10.1371/journal.pone.0043582. Epub 2012 Aug 24. PLoS One. 2012. PMID: 22937064 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,986 results

Search Page